Preview

Пульмонология

Расширенный поиск

Лимфангиолейомиоматоз: обзор литературы

https://doi.org/10.18093/0869-0189-2010-4-79-87

Полный текст:

Об авторах

С. И. Овчаренко
ГОУ ВПО "ММА им. И.М.Сеченова
Россия


Е. А. Сон
ГОУ ВПО "ММА им. И.М.Сеченова
Россия


Список литературы

1. Clements D., Chang W.Y.C., Johnson S.R. Lymphangioleiomyomatosis. Eur Respir. Mon. 2009; 46: 176-207.

2. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur. Respir. J. 2010; 35: 14-26.

3. von Stossel E. Uber muskulare Cirrhose der Lunge [Muscular cirrhosis of the lungs]. Beitr. Klin. Tuberk. 1937; 90: 432-442.

4. Urbun T., Lozor R., Lacronique J. et al. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Group d`Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM "O"P) [Study and research group on orphan lung disease]. Medicine (Baltimore) 1999; 78 (5): 321-337.

5. Johnson S.R., Taffersfield A.E. Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment. Am. J. Resrir. Crit. Care Med. 1999; 160 (2): 628-633.

6. Moss J., Avili N.A., Barnes P.M. et al. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am. J. Respir. Crit. Care Med. 2001; 164 (4): 669-671.

7. Yates J.R.W. Tuberous sclerosis. Eur. J. Hum. Genet. 2006; 14 (10): 1065-1073.

8. Osborne J.P., Fryer A., Webb D. Epidemiology of tuberous sclerosis. Ann. N. Y. Acad. Sci.1991; 615: 125-128.

9. Lutembacher R. Dyesmbryomes metatypiques des reinds; carcinose submallaire aigue du puomon avec emphseme generalise et double pneumothorax [Atypical kidney dysem-bryomas: acute submiliary carcinomatosis of the lung with emphysema and double pneumothorax]. Ann. Med. 1918; 5: 435-450.

10. Hancock E., Tomkins S., Sampson J. et al. Lymphangioleio! myomatosis and tuberous sclerosis. Respir. Med. 2002; 96: 7-13.

11. Castro M., Shepherd C.W., Gomez M.R. et al. Pulmonary tuberous sclerosis. Chest 1995; 107: 189-195.

12. Johnson S.R., Taffersfield A.E. Clinical experience of lymphangioleiomyomatosis in the UK. Thorax 2000; 55 (12): 1052-1057.

13. Oh Y.M., Mo E.K., Jang S.H. et al. Pulmonary lymphangioleiomyomatosis in Korea. Thorax 1999; 54: 618-621.

14. Hayashida M., Seyama K., Inoue Y. et al. The epidemiology of lymphangioleiomyomatosis in Japan: a nationwide cross sectional study of presenting features and prognostic factors. Respirology 2007; 12: 523-530.

15. Carsillo T., Astrinidis A., Henske E.P. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc. Natl. Acad. Sci. USA 2000; 97 (11): 6085-6090.

16. Чучалин А.Г. (ред.) Респираторная медицина. Руководство. М.; 2007; т. 2: 303-311.

17. Crooks D., Pacheco-Rodriguez G., DeCastro R. et al. Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis. Proc. Natl. Acad. Sci. USA 2004; 101: 17462-17467.

18. Hirama M., Atsura R., Mitani K. et al. Lymphangioleiomyomatosis diagnosed by immunocytochemical and genetic analysis of lymphangioleiomyomatosis cell clusters found in chylous pleural effusion. Intern. Med. 2007; 46: 1593-1596.

19. Sato T., Seyama K., Fujii H. et al. Mutation analysis of TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. J. Hum. Genet. 2002; 47 (1): 20-28.

20. Goncharova E.A., Goncharov D.A., Eszterhas A. et al. Tuberin regulates p70S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor sup pressor gene in pulmonary lymphangioleiomyomatosis (LAM). J. Biol. Chem. 2002; 277 (34): 30958-30967.

21. Pan C., Chung M., Ng K. et al. Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumor (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma. J. Pathol. 2008; 214: 387-393.

22. Pea M., Bonetti F., Zamboni G. et al. Clear cell tumor and angiomyolipoma. Am. J. Surg. Pathol. 1991; 15: 199-202.

23. Абелев Г.И., Эрайзер Т.Р. На пути к пониманию приро ды рака. Биохимия 2008; 73 (5): 605-618.

24. Seyama K., Kumasaka T., Souma S. et al. Vascular endothe lial growth factor-D in increased in serum of patients with lymphangioleiomyomatosis. Lymphat. Res. Biol. 2006; 4: 143-152.

25. Matsui K., Takeda K., Yu Z.X. et al. Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis. Arch. Pathol. Lab. Med. 2000; 124: 267-275.

26. Zhe X., Yang Y., Jakkaraju S. et al. Tissue inhibitor of metal loproteinase-3 downregulation in lymphangioleiomyomato sis: potential consequence of abnormal serum response factor expression. Am. J. Respir. Cell. Mol. Biol. 2003; 28: 504-511.

27. Клишко Е.В., Кондакова И.В., Чойнзонов Е.Л. Матрикс ные металлопротеиназы в онкогенезе. Сиб. онкол. журн. 2003; 2: 63-70.

28. Henry M.T., McMahol K., Mackarel A.J. et al. Matrix metalloproteinases and inhibitor of metalloproteinase-1 in sar coidosis and IPF. Eur. Respir. J. 2002; 20: 1220-1227.

29. Henske E.P. Metastasis of benign tumor cells in tuberous sclerosis complex. Genes Chromosom. Cancer 2003; 38: 376-381.

30. Karbowniczek M., Astrinidis A., Balsara B.R. et al. Recurrent lymphangioleiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am. J. Respir. Crit. Care Med. 2003; 167: 976-982.

31. Johnson S. Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax 1999; 54 (3): 254-264.

32. Ryu J.H., Moss J., Beck G.J. et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am. J. Respir. Crit. Care Med. 2006; 173 (1): 105-111.

33. Cohen M.M., Pollock1BarZiv S., Johnson S.R. Emerging clinical picture of lymphangioleiomyomatosis. Thorax 2005; 60: 875-879.

34. Sinclar W., Wright J.L., Churg A. Lymphangioleiomyomatosis presenting in postmenopausal women. Thorax 1985; 40: 75-76.

35. Logan R.F., Fawcett I.W. Oophorectomy for pulmonary lymphangioleiomyomatosis: a case report. Br. J. Dis. Chest 1985; 79: 98-100.

36. Tomasien A., Greenberg M.S., Rumerman H. Tamoxifen for lymphangioleiomyomatosis. N. Engl. J. Med. 1982; 306: 745-746.

37. Glassberg M.K., Elliot S.J., Fritz J. et al. Activation of the estrogen receptor contributes to the progression of pul monary lymphangioleiomyomatosis via MMP!induced cell invasiveness. J. Clin. Endocrinol. 2008; 93 (5): 1625-1633.

38. Matsui K., Takeda K., Yu Z.X. et al. Downregulation of estrogen and progestorone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomy omatosis following therapy. An immunohistochemical study. Am. J. Respir. Crit. Care Med. 2000; 161 (3, Pt 1): 1002-1009.

39. Каменева М.Ю., Двораковская И.В., Новикова Л.Н. и др. Лейомиоматоз легких (Морфофункциональное иссле дование). Болезни органов дыхания 2007; 1: 86-95.

40. Miyake M., Tateishi U., Maeda T. et al. Pulmonary lym phangioleiomyomatosis in a male patient with tuberous sclerosis complex. Radiat. Med. 2005; 23: 525-527.

41. Aubry M.1C., Myers J.L., Ryu J.H. et al. Pulmonary lym phangioleiomyomatosis in a man. Am. J. Respir. Crit. Care Med. 2000; 162: 749-752.

42. Fiore M.G., Sanguedolce F., Lolli I. et al. Abdominal lym phangioleiomyomatosis in a man with Klinefelter syndrome: the first reported case. Ann. Diagn. Pathol. 2005; 9: 96-100.

43. Schiavina M., Di Scioscio V., Contini P. et al. Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. Am. J. Respir. Crit. Care Med. 2007; 176: 96-98.

44. Sullivan E.J. Lymphangioleiomyomatosis: a review. Chest 1998; 114 (6): 1689-1703.

45. Перепечин В., Стеблянская О., Черняев А. и др. Диффузный лимфангиолейомиоматоз легких. Врач 2008; 2: 6-11.

46. Chu S.C., Horiba K., Usuki J. et al. Comprehensive evalua tion of 35 patients with lymphangioleiomyomatosis. Chest 1999; 115: 1041-1052.

47. Almoosa K.F., Ryu J.H., Mendez J. et al. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. Chest 2006; 129 (5): 1274-1281.

48. Ryu J.H., Doerr C.H., Fisher S.D. et al. Chylothorax in lym phangioleiomyomatosis. Chest 2003; 123: 623-627.

49. Corrin B., Liebow A.A. Friedman P.J. Pulmonary lymphan gioleiomyomatosis. Am. J. Pathol. 1975; 79: 348-382.

50. Matsui K., Tatsuguchi A., Valencia J. et al. Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic fea tures in 22 cases. Hum. Pathol. 2000; 31 (10): 1242-1248.

51. Avila N.A., Bechtle J., Dwyer A.J. et al. Lymphangioleiomyo matosis: CT of diurnal variation of lymphangioleiomyomas. Radiology 2001; 221 (2): 415-421.

52. Avila N.A., Kelly J.A., Chu S.C.et al. Lymphangioleiomyo matosis: abdominopelvic CT and US findings. Radiology 2000; 216 (1): 147-153.

53. Peh W.C., Law S., Fok M. et al. Case report: lymphangioleiomyomatosis with spontaneous peritoneal rupture. Br. J. Radiol. 1994; 67 (798): 605-608.

54. Gray S., Carrington C., Cornog J. Lymphangioleiomyomatosis: report of case with ureteral involvement and chy luria. Cancer (Phclad.) 1975; 35: 490-498.

55. Maziak D.E., Kesten S., Rappaport D.S. et al. Extrathoracic angiomyolipomas in lymphangioleiomyomatosis. Eur. Respir. J. 1996; 9: 402-405.

56. Bernstein S.M., Newell J.D., Adamczyk D. et al. How common are renal angiomyolipomas in patients with pulmonary lymphangioleiomyomatosis? Am. J. Respir. Crit. Care Med. 1995; 152: 2138-2143.

57. O`Callaghan F.J., Noakes M.J., Martyn C.N. et al. An epi demiological study of renal pathology in tuberous sclerosis complex. Br. J. Urol. International 2004; 94 (6): 853-857.

58. van Baal J.G., Smits N.J., Keeman J.N. et al. The evolution of renal angiomyolipomas in patients with tuberous sclerosis complex [comment]. J. Urol. (Baltimore) 1994; 152 (1): 35-38.

59. Ewalt D.H., Sheffield E., Sparagana S.P. et al. Renal lesion growth in children with tuberous sclerosis complex. J. Urol. (Baltimore) 1998; 160 (1): 141-145.

60. Roach E.S., DiMario F.J., Kandt R.S. et al. Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association. J. Child Neurol. 1999; 14 (6): 401-407.

61. Rakowski S.K., Winterkorn E.B., Paul E. et al. Renal mani festations of tuberous sclerosis complex: Incidence, progno sis, and predictive factors. Kidney Int. 2006; 70 (10): 1777-1782.

62. Lemaitre L., Robert Y., Dubrulle F. et al. Renal angiomyolipoma: growth followed up with CT and / or US. Radiology 1995; 197 (3): 598-602.

63. Avila N.A., Dwyer A.J., Rabel A. et al. Sporadic lymphangioleiomyomatosis and tuberous sclerosis complex with lymphangioleiomyomatosis: comparison of CT features. Radiology 2007; 242: 277-285.

64. Warth A., Herpel E., Schmahl A. et al. Mediastinal angiomy olipomas in a male patient affected by tuberous sclerosis. Eur. Respir. J. 2008; 31: 678-680.

65. L`Hostis H., Deminiere C., Ferriere J.M. et al. Renal angiomyolipoma: clinicopathologic, immunohistochemi cal, and followup study of 46 cases. Am. J. Surg. Pathol. 1999; 23: 1011-1020.

66. Steiner M.S., Goldman S.M., Fishman E.K. et al. The natural history of renal angiomyolipoma. J. Urol. (Baltimore) 1993; 150: 1782-1786.

67. Moss J., DeCastro R., Patronas N.J. et al. Meningiomas in lymphangioleiomyomatosis. J.A.M.A. 2001; 286 (15): 1879-1881.

68. Bonetti F., Chiodera P.L., Pea M. et al. Transbronchial biop sy in lymphangioleiomyomatosis of the lung. HMB!45 for diagnosis. Am. J. Surg. Pathol. 1993; 17 (11): 1092-1102.

69. Matsui K., Beasley M.B., Nelson W.K. et al. Prognostic sig nificance of pulmonary lymphangioleiomyomatosis histo logic score. Am. J. Surg. Pathol. 2001; 25 (4): 479-484.

70. Carrington C.B., Cugell D.W., Gaensler E.A. et al. Lymph angioleiomyomatosis. Physiologic-pathologic-radiologic correlations. Am. Rev. Respir. Dis. 1977; 116 (6): 977-995.

71. Matsumoto Y., Horiba K., Usuki J. et al. Markers of cell pro liferation and expression of melanosomal antigen in lymphangioleiomyomatosis. Am. J. Respir. Cell Mol. Biol. 1999; 21 (3): 327-336.

72. Zhe X., Schuger L. Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis. J. Histochem Cytochem 2004; 52 (12): 1537-1542.

73. Franz D.N., Brody A., Meyer C. et al. Mutational and radi ographic analysis of pulmonary disease consistent with lym phangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am. J. Respir. Crit. Care Med. 2001; 164 (4): 661-668.

74. Taveira-DaSilva A.M., Stylianou M.P., Hedin C.J. et al. Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone. Chest 2004; 126 (6): 1867-1874.

75. Lazor R., Valeyre D., Lacronique J. et al. Low initial KCO predicts rapid FEV1 decline in pulmonary lymphangi oleiomyomatosis. Respir. Med. 2004; 98 (6): 536-541.

76. Fujimoto M., Ohara N., Sasaki H. et al. Pregnancy compli cated with pulmonary lymphangioleiomyomatosis: case report. Clin. Exp. Obstetr. Gynecol. 2005; 32 (3): 199-200.

77. Brunelli A., Catalini G., Fianchini A. Pregnancy exacerbating unsuspected mediastinal lymphangioleiomyomatosis and chylothorax. Int. J. Gynaecol. Obstet. 1996; 52 (3): 289-290.

78. McLoughlin L., Thomas G., Hasan K. Pregnancy and lym phangioleiomyomatosis: anaesthetic management. Int. J. Obstetr. Anest. 2003; 12 (1): 40-44.

79. Yockey C.C., Riepe R.E., Ryan K. Pulmonary lymphangi oleiomyomatosis complicated by pregnancy. Kans. Med. 1986; 87 (10): 277-278, 293.

80. Warren S.E., Lee D., Martin V., Messink W. Pulmonary lym phangiomyomatosis causing bilateral pneumothorax during pregnancy. Ann. Thorac. Surg. 2000; 55 (4): 998-1000.

81. Raft J., Lalot J.M., Meistelman C., Longrois D. Renal angiomyolipoma rupture during pregnancy. Gynecol. Obstetr. Fertil. 2006; 34 (10): 917-919.

82. Storm D.W., Mowad J.J. Conservative management of a bleeding renal angiomyolipoma in pregnancy. Obstet. & Gynecol. 2006; 107 (2, Pt 2): 490-492.

83. Morales J.P., Georganas M., Khan M.S. et al. Embolization of a bleeding renal angiomyolipoma in pregnancy: case report and review. Cardiovasc. Intervent. Radiol. 2005; 28 (2): 265-268.

84. Mascarenhas R., McLaughlin P. Haemorrhage from angiomyolipoma of kidney during pregnancy - a diagnostic dilemma. Irish Med. J. 2001; 94 (3): 83-84.

85. Pollock-BarZiv S., Cohen M.M., Downey G.P. et al. Air trav el in women with lymphangioleiomyomatosis. Thorax 2007; 62 (2): 176-180.

86. Avila N.A., Dwyer A.J., Rabel A. et al. CT of pleural abnor malities in lymphangioleiomyomatosis and comparison of pleural findings after different types of pleurodesis. Am. J. Roentgenol. 2006; 186 (4): 1007-1012.

87. Wójcik P., Otto T., Jagiello R. et al. Use of pleuro-peritoneal shunt in the treatment of chronic chylothorax. Pneumonol. Alergol. Pol. 1998; 66: 473-479.

88. Taylor J.R., Ryu J., Colby T.V., Raffin.TA. Lymphangio leiomyomatosis. Clinical course in 32 patients. N. Engl. J. Med. 1990; 323 (18): 1254-1260.

89. Svendsen T.L., Viskum K., Hansborg N. et al. Pulmonary lymphangioleiomyomatosis: a case of progesterone receptor positive lymphangioleiomyomatosis treated with medrox yprogesterone, oophorectomy and tamoxifen. Br. J. Dis. Chest 1984; 78 (3): 264-271.

90. Morimoto N., Hirasaki S., Kamei T. et al. Pulmonary lymphangiomyomatosis (LAM) developing chylothorax. Intern Med 2000; 39(9): 738-741.

91. Christodoulou M., Ris H.1B., Pezzetta E. Video!assisted right supradiaphragmatic thoracic duct ligation for non-traumat ic recurrent chylothorax. Eur. J. Cardiothorac Surg. 2006; 29 (5): 810-814.

92. Druelle.S, Aubry P., Levi-Valensi P. Pulmonary lymphangiomyomatosis: a 3-year followup of medroxyprogesterone acetate therapy. Apropos of a case. Rev. Pneumol. Clin. 1995; 51 (5): 284-287.

93. Zanella A., Toppan P., Nitti D., Lise M. Pulmonary lymphangioleiomyomatosis: a case report in postmenopausal woman treated with pleurodesis and progesterone (medrox yprogesterone acetate). Tumori 1996; 82 (1): 96-98.

94. Yamakado K., Tanaka N., Nakagawa T. et al. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology 2002; 225 (1): 78-82.

95. Taveira-DaSilva A.M., Hedin C., Stylianou M.P. et al. Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis. Am.J. Respir. Crit. Care Med. 2001; 164 (6): 1072-1076.

96. Harari S., Cassandro R., Chiodini J. et al. Effect of a gonadotrophin!releasing hormone analogue on lung func tion in lymphangioleiomyomatosis. Chest 2008; 133 (2): 448-454.

97. Bissler J.J., McCormack F.X., Young L.R. et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphan gioleiomyomatosis. N. Engl. J. Med. 2008; 358 (2): 140-151.

98. Davies D.M., Johnson S.R., Tattersfield A.E. et al. Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis. N. Engl. J. Med. 2008; 358 (2): 200-203.


Для цитирования:


Овчаренко С.И., Сон Е.А. Лимфангиолейомиоматоз: обзор литературы. Пульмонология. 2010;(4):79-87. https://doi.org/10.18093/0869-0189-2010-4-79-87

Просмотров: 3


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)